What is NDC 0143-9750?

0143-9750 is the product NDC for Testosterone Enanthate, Testosterone enanthate 200 mg/mL injection, solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Testosterone Enanthate?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Testosterone Enanthate NDC 0143-9750

NDC codes

FDA NDC Directory

Product NDC (as listed)0143-9750Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00143-9750Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0143-9750-01	0014397500100143975001	5 mL in 1 VIAL, MULTI-DOSE (0143-9750-01)Marketed from Sep 18, 2012

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Testosterone Enanthate
Generic name (nonproprietary): testosterone enanthate
Active ingredients: Testosterone enanthate — 200 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular
Labeler: Hikma Pharmaceuticals USA Inc.NDC labeler code 0143
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091120
Marketing start: Sep 18, 2012
Listing expires: Dec 31, 2027
DEA schedule: CIII
Other FDA classes: Androgen Receptor Agonists (Mechanism)Androstanes (Chemical structure)
Identifiers: Product ID 0143-9750_8d67aa07-833f-4be7-8a7e-e49e19f49949SPL ID 8d67aa07-833f-4be7-8a7e-e49e19f49949SPL set ID e89d6458-428c-4256-97a3-f1fa851293c1RxCUI 835809UNII 7Z6522T8N9
Pharmacologic class: Androgen

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400143975001 followed by a unit qualifier and the quantity

Package 00143-9750-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 8, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Males Testosterone Enanthate Injection, USP is indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired) – Testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, or orchidectomy. Hypogonadotropic hypogonadism (congenital or acquired) – Gonadotropin or luteinizing hormone‑releasing hormone (LHRH) deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. (Appropriate adrenal cortical and thyroid hormone replacement therapy are still necessary, however, and are actually of primary importance.) If the above …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0143-9750

What is NDC 0143-9750?: 0143-9750 is the product NDC for Testosterone Enanthate, Testosterone enanthate 200 mg/mL injection, solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Testosterone Enanthate.
What is the active ingredient?: Testosterone enanthate.
Who is the labeler?: Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Testosterone Enanthate?: 1 other product NDC are listed under this name. See all Testosterone Enanthate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Testosterone Enanthate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Testosterone Enanthate	Testosterone enanthate 200 mg/mL	Injection, SolutionIntramuscular	Eugia US LLC	55150-336	55150-0336-01